|Year : 2018 | Volume
| Issue : 4 | Page : 379-388
Associations between Body Composition Indices and Metabolic Disorders in Chinese Adults: A Cross-Sectional Observational Study
Rong Zhang1, Sheng-Yong Dong2, Fei Wang3, Cong Ma3, Xiao-Lan Zhao4, Qiang Zeng3, Ao Fei5
1 International Medical Center, Health Management Institute, Chinese PLA General Hospital, Beijing 100853; Department of Cardiology, Chinese Navy General Hospital, Beijing 100048, China
2 Department of Healthcare, Agency for Offices Administration of PLA, Beijing 100048, China
3 International Medical Center, Health Management Institute, Chinese PLA General Hospital, Beijing 100853, China
4 Department of Health Management Center, Health Management Institute, Southwest Hospital, The Third Military Medical University, Chongqing 400038, China
5 Navy Institutional Organization, Beijing 100841, China
|Date of Submission||10-Nov-2017|
|Date of Web Publication||09-Feb-2018|
Prof. Qiang Zeng
Health Management Institute, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853
Source of Support: None, Conflict of Interest: None
Background: Obesity induces dyslipidemia, hypertension, glucose intolerance, and inflammatory state, which results in atherogenic processes, diabetes, and cardiovascular disease. We usually use body composition indices, such as body mass index (BMI), body fat percentage (BFP), waist circumference-height ratio (WHtR), and waist-hip ratio (WHR) to reflect the obesity. The aim of this large population-based cross-sectional study was to investigate the associations between body composition indices and metabolic parameters in Chinese adults.
Methods: A total of 12,018 Chinese adults were included. Body composition indices, such as BMI, BFP, WHtR, and WHR, and metabolic parameters, such as systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol (TC), triglyceride (TG), low-density lipoprotein-cholesterol (LDL-C), high-density lipoprotein-cholesterol (HDL-C), fasting blood glucose (FBG), 2 h postprandial blood glucose (2h PBG), glycosylated hemoglobin (HbA1c), fasting insulin (FINS), insulin resistance index (HOMA-IR), high-sensitivity C-reactive protein (hs-CRP), and white blood cell count (WBC), were measured and analyzed. All analyses were stratified by gender.
Results: All body composition indices and metabolic parameters except 2h PBG differed significantly between males and females (all P < 0.001). BMI was positively associated with SBP, DBP, LDL-C, TC, TG, FBG, 2h PBG, HbA1c, FINS, HOMA-IR, hs-CRP, and WBC, and inversely associated with HDL-C; similar relationships were identified between the metabolic parameters and BFP, WHtR, and WHR. In the multivariate analysis, the odds of impaired glucose regulation, dyslipidemia, insulin resistance, and increased hs-CRP were 1.36, 1.92, 3.44, and 1.27 times greater in the overweight group than those in the normal weight group, respectively, and 1.66, 3.26, 7.53, and 1.70 times greater in the obese group than those in the normal weight group, respectively. The odds of dyslipidemia and hs-CRP were 1.29 and 1.38 times greater in the BFP ≥28.0% group than in the BFP <28.0% group, respectively. The odds of dyslipidemia, HOMA-IR, and hs-CRP were 1.55, 1.26, and 1.48 times greater in the WHtR ≥0.96 group than in the WHtR <0.96 group, respectively. Among males, the odds of HOMA-IR were 1.46 times greater in the WHR ≥0.54 group than in the WHR <0.54 group. Similar results were observed in females.
Conclusions: This study identified positive associations between all evaluated body composition indices and metabolic parameters in Chinese adults. Among the body composition indices, BMI predicted four of the five evaluated metabolic disorders in both gender groups.
背景: 肥胖可导致血脂异常, 血压升高, 糖代谢异常, 炎症状态, 由此引发动脉粥样硬化, 糖尿病, 心血管疾病。 我们通常用身体成分指标, 如身体质量指数 (BMI), 体脂百分比 (BFP), 腰高比 (WHtR) 和腰臀比 (WHR) 反映肥胖程度。 本文通过对中国成人的横断面研究揭示身体成分指标和代谢参数之间的关系。
方法: 研究对象包括12018中国成年人. 身体成分指标包括: BMI, BFP, WHtR, WHR。 代谢参数包括: 收缩压 (SBP), 舒张压 (DBP), 总胆固醇 (TC), 甘油三酯 (TG), 低密度脂蛋白胆固醇 (LDL-C), 高密度脂蛋白胆固醇 (HDL-C), 空腹血糖 (FBG), 餐后2 h血糖 (2h PBG), 糖化血红蛋白 (HbA1c), 空腹胰岛素 (FINS), 胰岛素抵抗指数 (HOMA-IR), 高敏c反应蛋白 (hs-CRP), 和白细胞计数 (WBC)。 所有分析都按性别分层。
结果: 中国成年男性和女性相比, 除了2h PBG外, 所有身体成分指标及代谢参数之间存在显著统计学差异 (P < 0.001)。 BMI (WHtR, WHR) 与SBP, DBP, LDL-C, TC, TG, FBG, 2h PBG, HbA1c, FINS, HOMA-IR, hs-CRP 和WBC呈正相关, 与高密度脂蛋白胆固醇呈负相关。 多变量分析显示男性中, 以 BMI 为分组标准, 超重组的葡萄糖调节受损 (IGR), 血脂异常, 胰岛素抵抗和升高的高敏c反应蛋白 (hs-CRP) 分别为正常体重组的 1.36, 1.92, 3.44, 和 1.27 倍; 肥胖组分别为正常组的 1.66, 3.26, 7.53, 和 1.70 倍。 以BFP 为分组标准, BFP ≥28.0%组血脂异常, hs-CRP 异常的比例分别是 BFP <28.0% 组的 1.29 和 1.38 倍。 以 WHtR 为分组标准, WHtR ≥ 0.96 组血脂异常, HOMA-IR, hs-CRP 分别是 WHtR < 0.96 组的 1.55, 1.26, 和 1.48 倍。 以WHR为分组标准, WHR ≥0.54 组HOMA-IR是 WHR <0.54 组的 1.46 倍。 在女性中也观察到类似的结果。
结论: 本研究发现在中国成年人中身体成分指标和代谢参数之间存在正相关。 在不同性别中, 身体成分指标 BMI 可以预测五个代谢紊乱参数中的四个。
Keywords: Adults; Body Composition; Body Mass Index; Cardiovascular Disease; Metabolism
|How to cite this article:|
Zhang R, Dong SY, Wang F, Ma C, Zhao XL, Zeng Q, Fei A. Associations between Body Composition Indices and Metabolic Disorders in Chinese Adults: A Cross-Sectional Observational Study. Chin Med J 2018;131:379-88
|How to cite this URL:|
Zhang R, Dong SY, Wang F, Ma C, Zhao XL, Zeng Q, Fei A. Associations between Body Composition Indices and Metabolic Disorders in Chinese Adults: A Cross-Sectional Observational Study. Chin Med J [serial online] 2018 [cited 2018 Jun 25];131:379-88. Available from: http://www.cmj.org/text.asp?2018/131/4/379/225059
| Introduction|| |
Obesity induces adipocyte dysfunction, with the secretion of adipokines and macrophage activation leading to inflammatory cytokine production, which results in a cascade of reactions that influence metabolic parameters, atherogenic processes, and insulin sensitivity. In addition to its contribution as an independent cardiovascular disease (CVD) risk factor, obesity promotes alterations in other intermediate risk factors for CVD, such as dyslipidemia, hypertension (HTN), glucose intolerance, inflammatory states, obstructive sleep apnea hypoventilation syndrome, and a prothrombotic state; in addition, it is possible that many additional unknown mechanisms exist. Obesity also has been found to induce a variety of structural adaptations/alterations in cardiovascular structures/functions. Each year, 28 million individuals die as a consequence of overweight or obesity worldwide.
Body composition indices, such as the body mass index (BMI), body fat percentage (BFP), waist-hip ratio (WHR), and waist circumference-height ratio (WHtR), can be used as simple and inexpensive proxy measures of abdominal obesity. However, the determination of which measure is the best body composition index for predicting metabolic disorders and cardiovascular risk among Chinese adults remains under investigation.
In this large population-based cross-sectional study, we identified associations between different body composition indices (including BMI, BFP, WHR, and WHtR) and metabolic parameters and assessed which index was the best predictor of metabolic parameters.
| Methods|| |
The study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of Chinese PLA General Hospital, Beijing, China. Informed written consent was obtained from all participants prior to their enrolment in this study.
This cross-sectional study was conducted in the Physical Examination Center of Chinese PLA General Hospital using data from a completed national health survey that was carried out with the aim of determining the associations between body composition indices, such as BMI, BFP, WHtR, and WHR, and metabolic parameters in Chinese adults. The primary concerns of BMI, BFP, WHtR, and WHR are weight, fat content, abdominal obesity, and the central obesity, respectively. All participants were enrolled at the Physical Examination Center of Chinese PLA General Hospital between 2010 and 2013. The samples included 7185 males (mean age: 46.0 ± 8.8 years) and 4133 females (mean age: 46.4 ± 9.4 years). Participants were excluded if they did not have information available on demographic characteristics; body composition indices, such as weight, height, waist circumference (WC), hip circumference (HC), fat-free body mass, and BFP; or metabolic parameters, such as low-density lipoprotein-cholesterol (LDL-C), high-density lipoprotein-cholesterol (HDL-C), total cholesterol (TC), triglyceride (TG), fasting blood glucose (FBG), 2 h postprandial blood glucose (2h PBG), glycosylated hemoglobin (HbA1c), fasting insulin (FINS), insulin resistance index (HOMA-IR), high-sensitivity C-reactive protein level (hs-CRP), and white blood cell count (WBC). The exclusion criteria included the following: history of cancer, CVD, diabetes, liver disease, HTN, hematologic disease, chronic kidney disease, hypothyroidism, endocrine diseases, Cushing's syndrome, or polycystic ovary disease; use of anti-inflammatory drugs, antipsychotic drugs, steroids, or medications that promoted changes in adiposity; use of drug for regulating lipid; and pregnant or lactating status.
Anthropometric measurements were obtained from all participants while they were bare foot and dressed in light clothing. Body weight (measured to the nearest 0.1 kg) and height (measured to the nearest 0.1 cm) were measured. WC (measured to the nearest 0.1 cm) was measured midway between the inferior margin of the last rib and the crest of the ilium in a horizontal plane. We measured HC around the widest portion of the buttocks using a nonelastic tape to the nearest 0.1 cm. BMI was calculated by dividing weight (kg) by height squared (m 2). WHtR was calculated as WC (cm) divided by height (cm). WHR was calculated as HC (cm) divided by height (cm). BFP was measured using a tetra-polar bioelectrical impedance device (ARTEMIS body composition analyzer HRV system, Korea). Blood pressure was measured in the right arm 5 min after rest using a recently calibrated electronic sphygmomanometer while the participant was in the supine position. All anthropometric measurements were obtained by trained staff using standardized protocols.
Blood samples were obtained before breakfast to measure the levels of FBG, LDL-C, HDL-C, TC, TG, 2h PBG, HbA1c, FINS, hs-CRP, and WBC. Two hours after breakfast, peripheral venous blood samples were obtained to measure 2h PBG, and HOMA-IR was calculated using the following formula: (insulin [mU/ml] × glucose [mmol/L])/22.5. All blood samples were analyzed at the laboratory of the Physical Examination Center of Chinese PLA General Hospital. The laboratory was affiliated with a top tertiary hospital and utilized a standardized and certified method of blood testing.
Definitions and classification of obesity
Current recommendations suggest that “BMI cutoff points should be set differently for Asian populations” and “BMI should be established on the basis of ethnic and racial background.” Thus, we used the recommended cutoff values for overweight and obesity in Chinese populations, as follows: 18.5 kg/m 2 ≤ BMI ≤ 24.0 kg/m 2 (normal weight), 24.0 kg/m 2< BMI < 28.0 kg/m 2 (overweight), and ≥28.0 kg/m 2 (obesity). We then stratified all participants into normal weight, overweight, and obese groups according to BMI. The criterion for obesity, as defined by BFP, was having a BFP in the top tertile defined for each gender, which was ≥28.0% in males and ≥35.0% in females. We stratified all participants by BFP category as being of normal weight (BFP <28.0% in males and <35.0% in females) or obesity (BFP ≥28.0% in males and ≥35.0% in females). The criterion for obesity, as defined by WHtR, was having a WHtR in the top tertile defined for each gender, which was ≥0.96 in males and ≥0.85 in females. We stratified all participants into the following WHtR category: normal weight (WHtR <0.96 in males and <0.85 in females) and obesity (WHtR ≥0.96 in males and ≥0.85 in females). The criterion for obesity, as defined by WHR, was having a WHR in the top tertile defined for each gender, which was ≥0.54 in males and ≥0.51 in females. We stratified all participants into these WHR category as being of normal weight (WHR <0.54 in males and <0.51 in females) or obesity (WHR ≥0.54 in males and ≥0.51 in females).
Definition of metabolic disorders
Impaired glucose regulation (IGR) was defined as having FBG level ≥6.1 mmol/L and <7.0 mmol/L and/or 2h PBG level ≥7.8 mmol/L and <11.1 mmol/L. Dyslipidemia was defined as having TC ≥5.18 mmol/L (2000 mg/L) and ≤6.18 mmol/L (2390 mg/L); TG ≥1.70 mmol/L (1500 mg/L) and ≤2.25 mmol/L (1990 mg/L); LDL-C ≥3.37 mmol/L (1300 mg/L) and ≤4.12 mmol/L (1590 mg/L); and/or HDL-C <1.04 mmol/L (400 mg/L). The criterion for IR was having an IR in the top tertile of the HOMA-IR defined for each gender, which was ≥2.9 in males and ≥2.2 in females. The criterion for hs-CRP was having a hs-CRP in the top tertile defined for each gender, which was ≥0.19 mg/L in males and ≥0.16 mg/L in females. The criterion for WBC was having a WBC in top tertile defined for each gender, which was ≥6.5 × 109/L in males and ≥5.8 × 109/L in females.
Data are expressed as mean ± standard deviation (SD). The distributions of all variables were tested for normality. Variables with abnormal distributions are presented as median (Q1, Q3) and were logarithmically transformed before analyses. Participants were categorized and analyzed by gender in all analyses. The differences in age, BMI, BFP, WHtR, WHR, systolic blood pressure (SBP), diastolic blood pressure (DBP), FBG, 2h PBG, LDL-C, HDL-C, TC, TG, HbA1c, FINS, hs-CRP, and WBC between males and females were compared using the one-way analysis of variance (ANOVA). Pearson's tests were performed to investigate the correlations between the four different body composition indices and metabolic parameters. Differences between the metabolic parametric values identified in the overweight/obese groups (as defined by BMI, BFP, WHtR, and WHR) and in the normal weight group were evaluated using the one-way ANOVA in each gender group. Finally, the metabolic parameters were divided into five sectors (dyslipidemia, IGR, IR, increased hs-CRP, and increased WBC). We calculated odds ratios for the comparisons of dyslipidemia, IGR, IR, and increased hs-CRP between the overweight/obese group and normal weight group when defined by BMI, BFP, WHtR, and WHR using multivariate logistic regression models. All statistical analyses were performed using SPSS version 19.0 software (SPSS Inc., Chicago, IL, USA), and a P < 0.05 was considered statistically significant.
| Results|| |
The general and clinical characteristics of the study participants are listed in [Table 1]. All parameters (age, BMI, BFP, WHtR, WHR, SBP, DBP, FBG, LDL-C, HDL-C, TC, TG, HbA1c, FINS, hs-CRP, and WBC) except 2h PBG differed significantly between males and females (all P < 0.05). Compared to males, females were older; had lower body composition index values, including BMI, WHtR, and WHR; and had lower values identified for all metabolic parameters except BFP and HDL-C.
|Table 1: Demographic and clinical characteristics of all participants in the study|
Click here to view
Correlations between body composition indices and metabolic parameters
Correlations between body composition indices and metabolic parameters are listed in [Table 2]. Among males, body composition indices, such as BMI, BFP, WHtR, and WHR, were correlated with SBP, DBP, LDL-C, TC, TG, HDL-C, FBG, 2h PBG, HbA1c, FINS, HOMA-IR, hs-CRP, and WBC. BMI was more strongly correlated with SBP, TG, HDL-C, FBG, and HOMA-IR than other metabolic parameters; BFP was more strongly correlated with DBP, LDL-C, TC, and hs-CRP; WHtR and WHR were more strongly correlated with WBC and 2h PBG, respectively. Among females, adiposity measurements, such as BMI, BFP, WHtR, and WHR, were also correlated with SBP, DBP, LDL-C, TC, TG, HDL-C, FBG, 2h PBG, HbA1c, FINS, HOMA-IR, hs-CRP, and WBC. BMI was more strongly correlated with HDL-C, FINS, and WBC; WHR was most strongly correlated with SBP, DBP, LDL-C, TC, FBG, 2h PBG, and hs-CRP.
|Table 2: Correlations between body composition indices and metabolic parameters|
Click here to view
One-way analysis of variance of associations between body composition indices and metabolic parameters
Comparisons of metabolic parametric values in participants stratified by body composition indices (BMI, BFP, WHtR, and WHR) are listed in [Table 3],[Table 4],[Table 5],[Table 6], respectively. When we stratified the participants by BMI as being of normal weight, overweight, or obese, the values for SBP, DBP, LDL-C, HDL-C, TC, TG, FBG, 2h PBG, HbA1c, FINS, HOMA-IR, hs-CRP, and WBC differed significantly among the normal weight, overweight and obese groups in both males and females. Similarly, the values for SBP, DBP, LDL-C, HDL-C, TC, TG, FBG, 2h PBG, HbA1c, FINS, HOMA-IR, hs-CRP, and WBC were also significantly different between the obese group and normal weight group when the groups were defined by BFP, WHtR, and WHR.
|Table 3: Comparisons of metabolic parameter values by BMI category among the study participants|
Click here to view
|Table 4: Comparisons of metabolic parametric values by BFP category among the study participants|
Click here to view
|Table 5: Comparisons of metabolic parametric values by WHtR category among the study participants|
Click here to view
|Table 6: Comparisons of metabolic parametric values by WHR category among the study participants|
Click here to view
Multivariate logistic regression analysis of the associations between body composition indices and metabolic disorders
Multivariate logistic regression analyses of the associations between body composition indices and metabolic disorders are listed in [Table 7]. In the multivariate analyses adjusted for age, SBP, BMI, BFP, WHtR, and WHR, among males, the odds of having IGR, dyslipidemia, HOMA-IR, and increased hs-CRP were 1.36, 1.92, 3.44, and 1.27 times greater in the overweight group and 1.66, 3.26, 7.53, and 1.70 times greater in the obese group, respectively, when those of normal weight were used as the reference group. The odds of WBC did not differ significantly between the overweight group and the normal weight group, as defined by BMI. The odds of dyslipidemia and hs-CRP in the BFP ≥28.0% group were 1.29 and 1.38 times greater than those of the BFP <28.0% group, respectively, while the odds of IGR, HOMA-IR, and increased WBC did not differ significantly between these two groups. The odds of dyslipidemia, HOMA-IR, and increased hs-CRP in the WHtR ≥0.96 group were 1.55, 1.26, and 1.48 times greater than those of the WHtR <0.96 group, while the odds of IGR and increased WBC did not differ significantly between two groups. The odds of HOMA-IR in the WHR ≥0.54 group were 1.46 times greater than that of the WHR <0.54 group, while the odds of dyslipidemia, IGR, increased WBC, and increased hs-CRP did not differ significantly between the two groups.
|Table 7: Multivariate logistic regression analyses of the associations between body composition indices and metabolic disorders|
Click here to view
Among females, the odds of HOMA-IR, hs-CRP, and increased WBC were 2.60, 1.48, and 1.64 times greater in the overweight group and 3.59, 2.63, and 2.25 times greater in the obese group, respectively, when those of normal weight were used as the reference group. The odds of dyslipidemia in the overweight group were 1.57 times greater than that of the normal weight group, as defined by BMI. The odds of IGR did not differ significantly between these groups. The odds of increased hs-CRP and WBC in the BFP ≥35.0% group were 1.28 and 1.27 times greater than those of the BFP <35.0% group, while the odds of dyslipidemia, IGR, and HOMA-IR did not differ significantly between the two groups. The odds of dyslipidemia, hs-CRP, and increased WBC in the WHtR ≥0.85 group were 1.40, 1.42, and 1.36 times greater than those of the WHtR <0.85 group; however, significant differences were not identified in IGR and HOMA-IR. The odds of IR and increased hs-CRP in the WHR ≥0.51 group were 1.27 and 1.25 times greater than those of the WHR <0.51 group, while the odds of dyslipidemia and increased WBC did not differ significantly between the two groups.
| Discussion|| |
Statistically significant gender differences were identified in the metabolic parameters. These data demonstrated the presence of significant linear correlations between body composition indices and metabolic parameters in each gender group. Among males, we observed that BMI, rather than BFP, WHtR, and WHR, was the best predictor of IGR, dyslipidemia, HOMA-IR, and increased hs-CRP. Among females, BMI was the best predictor of IGR, dyslipidemia, HOMA-IR, increased hs-CRP, and increased WBC. Our findings suggest that BMI, an adiposity indicator, was associated with the majority of metabolic parameters, thus serving as an adequate tool for the detection of individuals at high risk for CVD.
Global BMI cutoff points for overweight (BMI ≥25.0 kg/m 2) and obesity (BMI ≥30.0 kg/m 2) have been set by the World Health Organization (WHO). Several studies in Asian populations have reported an association between increased atherogenic risk factors and having a BMI >22.3 kg/m 2. The studies suggested that Asians had higher body fat content and were at greater risk of diabetes, high blood pressure, and heart disease than people with the same BMI of other ethnicities. Lowering the BMI limits for Asian ethnic groups has been presented in several original articles ,,,,, and reviews ,,,,, and considered by the WHO., Current recommendations state that “BMI cutoff points should be set differently for Asian populations” and “BMI should be established on the basis of ethnic and racial background.” Therefore, we used the BMI cutoff values recommended for Asian populations.
Yoon et al. reported that impaired insulin secretion might be induced by insufficient β-cell mass, and BMI has been found to be linearly correlated with β-cell mass in normal and type 2 diabetic patients. Das et al. found that both obese males and females demonstrated higher fasting serum glucose and HbA1c levels. Positive correlations have been observed between BMI and both fasting serum glucose and HbA1c. Among obese persons, higher BMI values may be directly associated with an increase in the risk of metabolic diseases, such as type 2 diabetes mellitus (DM). Netjasov et al. found that BMI and glucose level were significantly and positively correlated among the obese and overweight females with a BMI ≥25.0 kg/m 2. Khoo et al. found that BMI was directly associated with HOMA-IR across all ethnic groups. The associations between BMI and its metabolic pathways were significantly stronger in Chinese than other ethnic group populations (Malays and Asian-Indians). The increase in HOMA-IR associated with each unit increase in BMI was greater among Chinese individuals than that of other ethnic groups; therefore, maintaining normal BMI may be important in the effort to prevent early onset of type 2 DM. In the prospective study conducted by Blüher et al., stronger associations were observed between BMI and both insulin and HOMA-IR, rather than either WC or total fat mass, as measured by dual-energy X-ray absorptiometry. DeLoach et al. concluded that BMI alone would be sufficient to estimate cardiovascular risk in children and adults. In adolescents, insulin resistance has been found to be strongly associated with BMI. In our cross-sectional study, we found that the prevalence of insulin resistance in the overweight group was 3.44 times greater than that of the normal weight group, while in the obese group, the prevalence of HOMA-IR was 7.53 times greater than that identified in the normal weight group when groups were defined by BMI. In addition, among females, the prevalence of insulin resistance in the overweight group was 1.48 times greater than that identified in the normal weight group, while in the obese group, the prevalence of HOMA-IR was 3.59 times greater than the prevalence observed in the normal weight group.
Increases in BMI might affect lipid parameters. In India, a significant relationship was identified between BMI and lipid profile (higher concentrations of TC, LDL, and TG) in obese children. Abnormal lipid levels were also observed in a much larger population of children with overweight in the United States, and in that study, the children with the highest BMI levels had the lowest HDL levels. Torng et al. showed that menopause was associated with significant increases in TC, LDL-C, and TG. TC, LDL-C, and TG increased consistently in association with BMI in middle-aged females, regardless of menopausal status. Furthermore, Netjasov et al. reported the identification of significant negative correlations between BMI and HDL in obese and overweight females with a BMI ≥25.0 kg/m 2. Gaining weight was associated with dyslipidemia in another study, confirming the increased incidence of metabolic abnormalities during menopause. In a lipid glucose study conducted in Tehran, significant associations between BMI and various types of dyslipidemia were observed; however, WHR only maintained a significant association with hypertriglyceridemia and low HDL-C., In China, increased BMI was found to be associated with increased TC and TG, and a negative association was ascertained between HDL and BMI. We found that there were significant correlations between BMI and lipid levels (LDL-C, HDL-C, TC, and TG), and when compared with the normal weight group, as defined by BMI, the odds of dyslipidemia in the overweight and obese groups were 2.60 and 3.59 times greater, respectively.
Khoo et al. found that BMI was directly associated with CRP across all evaluated ethnic groups. When compared with Chinese and Malay individuals, Asian-Indian persons were found to have higher CRP levels. The increase in CRP associated with each unit increase in BMI was greater in Chinese than that in other ethnic group populations. Other authors have reported that there was an association between CRP and BMI or between CRP and WHR. Among middle-aged and elderly African-Americans enrolled in the Jackson Heart Study, in which hs-CRP was used as a measure of inflammation, there was a strong correlation between BMI and CRP. Studies have shown that higher BMI levels were associated with higher CRP levels.
Other studies have indicated that the WBC was independently associated with obesity.,, Pratley et al. found that WBC was positively correlated with BMI when researching the relationships between WBC and obesity in persons of different races and genders. Increases in total WBC and WBC subtypes were found to be positively associated with the presence of metabolic syndrome in Chinese people. In addition, in our study, BMI was correlated with hs-CRP and WBC. We stratified females and males by BMI into normal weight, overweight, and obese groups. The measures for hs-CRP and WBC differed significantly among the normal weight, overweight and obese groups. Among males, when groups were defined by BMI, hs-CRP was 1.27 times greater in the overweight group and 1.70 times greater in the obese group than that of the normal weight group. Among females, the odds of hs-CRP and WBC were 1.48 and 1.64 times greater in the overweight group and 2.63 and 2.25 times greater in the obese group, respectively, when those of normal weight were used as the reference group.
Increased BMI has been found to be associated with the development of cardiovascular risk factors, such as HTN, dyslipidemia, insulin resistance, and DM, potentially leading to ischemic stroke and CVDs, including angina, myocardial infarction (MI), heart failure, and sudden death.,,,,, These comorbidities have been found to develop proportionately with increases in BMI, and obesity has been considered an independent risk factor for CVD., A recent large study included a cohort of 111,847 patients with non-ST elevation MI (NSTEMI). In that study, a strong, inverse linear relationship between BMI and age atfirst NSTEMI was observed. In children, increased BMI was found to be positively associated with the risk of premature death in a population of American-Indians born between 1945 and 1984 and followed between February 1966 and December 2003. Another study including older children also identified a close relationship between BMI at adolescence and the rate of all-cause mortality during adulthood.
To our knowledge, a large population-based cross-sectional study has not previously been conducted to compare the predictive abilities of BMI, BFP, WHR, and WHtR in the assessment of cardiometabolic risk factors in a population of Chinese adults. Based on the results of this study, we suggested that BMI might be more effective in the detection of metabolic disorders (IGR, dyslipidemia, insulin resistance, hs-CRP, and WBC) than the other evaluated indices. BMI is an adiposity indicator that was associated with the majority of the metabolic parameters studied, suggesting that BMI may serve as an better tool for cardiovascular risk factor detection than the other anthropometric measures included in our study. Thus, BMI might be of paramount importance for the prevention, optimum management, and prognostication of metabolic disorders and cardiometabolic risk factors. BMIs are inexpensive to measure, easy to use, and noninvasive and, therefore, can be widely used.
Several limitations of our study should be considered. First, the use of a cross-sectional design did not allow us to infer causality. Second, the results of our study may not be generalizable to other racial and ethnic groups because only Chinese adults were enrolled. Finally, participants were enrolled from a single center, which not only enhanced the internal validity of the comparisons, but also created some limitations in terms of generalizability.
In conclusion, this study analyzed data from 12,018 Chinese adults and identified positive associations between all evaluated body composition indices and metabolic parameters in both males and females. Among the body composition indices, BMI predicted almost all metabolic disorders in both gender groups. Our findings suggest that BMI could be regarded as an adequate tool for the detection of individuals at high risk for CVD.
The authors thank all participants for their important contributions.
Financial support and sponsorship
This work was supported by grants from the Military Healthcare Program (Nos. 15BJZ48, 09BJZ03, and 16BJZ40).
Conflicts of interest
There are no conflicts of interest.
| References|| |
Hermsdorff HH, Zulet MA, Puchau B, Martínez JA. Central adiposity rather than total adiposity measurements are specifically involved in the inflammatory status from healthy young adults. Inflammation 2011;34:161-70. doi: 10.1007/s10753-010-9219-y.
Emerging Risk Factors Collaboration, Wormser D, Kaptoge S, Di Angelantonio E, Wood AM, Pennells L, et al.
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: Collaborative analysis of 58 prospective studies. Lancet 2011;377:1085-95. doi: 10.1016/s0140-6736(11)60105-0.
Poirier P, Martin J, Marceau P, Biron S, Marceau S. Impact of bariatric surgery on cardiac structure, function and clinical manifestations in morbid obesity. Expert Rev Cardiovasc Ther 2004;2:193-201. doi: 10.1586/14779072.2.2.193.
Zeng Q, Dong SY, Sun XN, Xie J, Cui Y. Percent body fat is a better predictor of cardiovascular risk factors than body mass index. Braz J Med Biol Res 2012;45:591-600. doi: 10.1590/S0100-879X2012007500059.
Seidell JC, Kahn HS, Williamson DF, Lissner L, Valdez R. Report from a centers for disease control and prevention workshop on use of adult anthropometry for public health and primary health care. Am J Clin Nutr 2001;73:123-6.
Chen C, Lu FC; Department of Disease Control Ministry of Health, PR China. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci 2004;17 Suppl:1-36.
Xu Z, Qi X, Dahl AK, Xu W. Waist-to-height ratio is the best indicator for undiagnosed type 2 diabetes. Diabet Med 2013;30:e201-7. doi: 10.1111/dme.12168.
Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults (in Chinese). Chin J Cardiol 2007;35:390-419. doi: 10.3760/j.issn: 0253-3758.2007.05.003.
Wang J, Thornton JC, Burastero S, Shen J, Tanenbaum S, Heymsfield SB, et al.
Comparisons for body mass index and body fat percent among Puerto Ricans, blacks, whites and Asians living in the New York city area. Obes Res 1996;4:377-84. doi: 10.1002/j.1550-8528.1996.tb00245.x.
Gallagher D. Overweight and obesity BMI cut-offs and their relation to metabolic disorders in Koreans/Asians. Obes Res 2004;12:440-1. doi: 10.1038/oby.2004.48.
Araneta MR, Wingard DL, Barrett-Connor E. Type 2 diabetes and metabolic syndrome in Filipina-American women: A high-risk nonobese population. Diabetes Care 2002;25:494-9. doi: 10.2337/diacare.25.3.494.
Deurenberg P. Universal cut-off BMI points for obesity are not appropriate. Br J Nutr 2001;85:135-6. doi: 10.1079/BJN2000273.
Deurenberg P, Deurenberg-Yap M, Foo LF, Schmidt G, Wang J. Differences in body composition between Singapore Chinese, Beijing Chinese and dutch children. Eur J Clin Nutr 2003;57:405-9. doi: 10.1038/sj.ejcn.1601569.
Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: A meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 1998;22:1164-71. doi: 10.1038/sj.ijo.0800741.
Vikram NK, Pandey RM, Misra A, Sharma R, Devi JR, Khanna N, et al.
Non-obese (body mass index < 25 kg/m2) Asian Indians with normal waist circumference have high cardiovascular risk. Nutrition 2003;19:503-9. doi: 10.1016/S0899-9007(02)01083-3.
Dudeja V, Misra A, Pandey RM, Devina G, Kumar G, Vikram NK, et al.
BMI does not accurately predict overweight in Asian Indians in Northern India. Br J Nutr 2001;86:105-12. doi: 10.1079/BJN2001382.
Vikram NK, Misra A, Pandey RM, Dudeja V, Sinha S, Ramadevi J,et al
. Anthropometry and body composition in Northern Asian Indian patients with type 2 diabetes: Receiver operating characteristics (ROC) curve analysis of body mass index with percentage body fat as standard. Diabetes Nutr Metab 2003;16:32-40.
Misra A. Ethnic-specific criteria for classification of body mass index: A perspective for Asian Indians and American Diabetes Association Position Statement. Diabetes Technol Ther 2015;17:667-71. doi: 10.1089/dia.2015.0007.
Misra A. Revisions of cutoffs of body mass index to define overweight and obesity are needed for the Asian-ethnic groups. Int J Obes Relat Metab Disord 2003;27:1294-6. doi: 10.1038/sj.ijo.0802412.
Misra A. Redefining obesity in Asians: More definitive action is required from the WHO. Natl Med J India 2004;17:1-4.
Misra A, Misra R, Wijesuriya M, Banerjee D. The metabolic syndrome in South Asians: Continuing escalation and possible solutions. Indian J Med Res 2007;125:345-54.
] [Full text]
Medeirosneto G, Halpern A, Bouchard C. Progress in Obesity Research. Vol. 9. London: John Libbey Eurotext; 2003.
Abstracts of the 9th
International Congress on Obesity. Sao Paulo, Brazil, 24-29 August 2002. Int J Obes Relat Metab Disord 2002;26 Suppl 1:S1-245. doi: 10.1038/sj.ijo.0802104.
Pacific World Health Organization Regional Office for the Western. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Sydney: Health Communications Australia; 2000.
WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-63. doi: 10.1016/s0140-6736(03)15268-3.
Yoon KH, Ko SH, Cho JH, Lee JM, Ahn YB, Song KH, et al.
Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 2003;88:2300-8. doi: 10.1210/jc.2002-020735.
Das RK, Nessa A, Hossain MA, Siddiqui NI, Hussain MA. Fasting serum glucose and glycosylated hemoglobin level in obesity. Mymensingh Med J 2014;23:221-8.
Netjasov AS, Vujović S, Ivović M, Tancić-Gajić M, Marina L, Barać M, et al.
Relationships between obesity, lipids and fasting glucose in the menopause. Srp Arh Celok Lek 2013;141:41-7. doi: 10.2298/SARH1302041s.
Khoo CM, Sairazi S, Taslim S, Gardner D, Wu Y, Lee J, et al.
Ethnicity modifies the relationships of insulin resistance, inflammation, and adiponectin with obesity in a multiethnic Asian population. Diabetes Care 2011;34:1120-6. doi: 10.2337/dc10-2097.
Blüher S, Molz E, Wiegand S, Otto KP, Sergeyev E, Tuschy S, et al.
Body mass index, waist circumference, and waist-to-height ratio as predictors of cardiometabolic risk in childhood obesity depending on pubertal development. J Clin Endocrinol Metab 2013;98:3384-93. doi: 10.1210/jc.2013-1389.
DeLoach S, Keith SW, Gidding SS, Falkner B. Obesity associated inflammation in African American adolescents and adults. Am J Med Sci 2014;347:357-63. doi: 10.1097/MAJ.0b013e31829555f0.
Ishizaka N, Ishizaka Y, Toda E, Koike K, Nagai R, Yamakado M, et al.
Impact of changes in waist circumference and BMI over one-year period on serum lipid data in Japanese individuals. J Atheroscler Thromb 2009;16:764-71. doi: 10.5551/jat.2428.
Kaur S, Kapil U. Dyslipidemia amongst obese children in national capital territory (NCT) of Delhi. Indian J Pediatr 2011;78:55-7. doi: 10.1007/s12098-010-0263-2.
Cook S, Kavey RE. Dyslipidemia and pediatric obesity. Pediatr Clin North Am 2011;58:1363-73, ix. doi: 10.1016/j.pcl.2011.09.003.
Torng PL, Su TC, Sung FC, Chien KL, Huang SC, Chow SN, et al.
Effects of menopause and obesity on lipid profiles in middle-aged Taiwanese women: The Chin-Shan Community Cardiovascular Cohort Study. Atherosclerosis 2000;153:413-21. doi: 10.1016/S0021-9150(00)00423-8.
Mehdi H. Central obesity as a reliable predictor for hypertension and dyslipidemia: Tehran lipid glucose study. Iran J Endocrinol Metab 2010;12:251-9.
Yeganeh MZ, Shakersain B, Azizi F, Yngve A, Hedayati M. Central obesity as a reliable predictor for hypertension and dyslipidemia: Tehran lipid glucose study. Iran J Endocrinol Metab 2010;12:251-9.
Gui MH, Ling Y, Liu L, Jiang JJ, Li XY, Gao X. Effect of Metabolic Syndrome Score, Metabolic Syndrome, and Its Individual Components on the Prevalence and Severity of Angiographic Coronary Artery Disease. Chin Med J 2017;130:669-77. doi: 10.4103/0366-6999.201611.
] [Full text]
Gillum RF. Association of serum C-reactive protein and indices of body fat distribution and overweight in Mexican American children. J Natl Med Assoc 2003;95:545-52.
Friedman GD, Tekawa I, Grimm RH, Manolio T, Shannon SG, Sidney S, et al.
The leucocyte count: Correlates and relationship to coronary risk factors: The CARDIA study. Int J Epidemiol 1990;19:889-93. doi: 10.1093/ije/19.4.889.
Nanji AA, Freeman JB. Relationship between body weight and total leukocyte count in morbid obesity. Am J Clin Pathol 1985;84:346-7. doi: 10.1093/ajcp/84.3.346.
Nieto FJ, Szklo M, Folsom AR, Rock R, Mercuri M. Leukocyte count correlates in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 1992;136:525-37. doi: 10.1093/oxfordjournals.aje.a116530.
Pratley RE, Wilson C, Bogardus C. Relation of the white blood cell count to obesity and insulin resistance: Effect of race and gender. Obes Res 1995;3:563-71. doi: 10.1002/j.1550-8528.1995.tb00191.x.
Su BY, Tian CF, Gao BL, Tong YH, Zhao XH, Zheng Y, et al.
Correlation of the leucocyte count with traditional and non-traditional components of metabolic syndrome. Postgrad Med 2016;128:805-9. doi: 10.1080/00325481.2016.1243980.
Rabkin SW, Mathewson FA, Hsu PH. Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: The Manitoba Study. Am J Cardiol 1977;39:452-8. doi: 10.1016/S0002-9149(77)80104-5.
Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968-77. doi: 10.1161/01.CIR.67.5.968.
Wilkins K, Campbell NR, Joffres MR, McAlister FA, Nichol M, Quach S,et al
. Blood pressure in Canadian adults. Health Rep 2010;21:37-46.
Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al.
Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss: An update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006;113:898-918. doi: 10.1161/circulationaha.106.171016.
Xue W, Deng Y, Wang YF, Sun AJ. Effect of Half-dose and Standard-dose Conjugated Equine Estrogens Combined with Natural Progesterone or Dydrogesterone on Components of Metabolic Syndrome in Healthy Postmenopausal Women: A Randomized Controlled Trial. Chin Med J 2016;129:2773-9. doi: 10.4103/0366-6999.194646.
] [Full text]
Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al.
Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol 2006;26:968-76. doi: 10.1161/01.ATV.0000216787.85457.f3.
Poirier P, Eckel RH. Obesity and cardiovascular disease. Curr Atheroscler Rep 2002;4:448-53. doi: 10.1007/s11883-002-0049-8.
Madala MC, Franklin BA, Chen AY, Berman AD, Roe MT, Peterson ED, et al.
Obesity and age offirst non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 2008;52:979-85. doi: 10.1016/j.jacc.2008.04.067.
Franks PW, Hanson RL, Knowler WC, Sievers ML, Bennett PH, Looker HC, et al.
Childhood obesity, other cardiovascular risk factors, and premature death. N
Engl J Med 2010;362:485-93. doi: 10.1056/NEJMoa0904130.
Engeland A, Bjørge T, Søgaard AJ, Tverdal A. Body mass index in adolescence in relation to total mortality: 32-year follow-up of 227,000 Norwegian boys and girls. Am J Epidemiol 2003;157:517-23. doi: 10.1093/aje/kwf219.
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6], [Table 7]